MI/25/67 Glasswash Operative

Key Details

Job ID:
MI/25/67
Role:
Glsaswash Operative
Area:
Salary:
£24,546-£26,734 per annum dependent upon experience
Closing date:
20th January 2026

About the role

We are currently looking for a Glasswash Operative to join the Lab Services team at Cancer Research UK Manchester Institute. The aim of this post is to provide support to the laboratory areas by the provision of clean lab glassware, plastics and fluids.

You will be based in the Lab Services Department and be responsible for operating glasswashers and autoclaves to process the cleaning and sanitizing of glassware and plasticware collected from our research laboratories.

There is no direct lab contact with this support role.

About you

You should have experience of working within a team and experience of Manual Handling. You should be able to accurately carry out routine tasks following instructions closely. Previous experience working in a similar role is desirable, however, on the job training will be provided.

Laboratory Workers at Cancer Research UK Manchester Institute

More information

Mark Craven

Mark Craven provides essential resources for the smooth running of research across the Institute, including providing sterile glassware and plasticware for Core Facilities and Research Groups.

Lab Services Department

The Laboratory Services Department has space in both the Paterson Building and the Oglesby Cancer Research Building (OCRB) to provide 6 main functions to cover all researchers in both buildings.

About CRUK Manchester Institute

Our aim is to understand the fundamental basis of cancer and apply that knowledge to developing new treatment strategies for cancer patients. Our advanced research programmes span a spectrum of cancer research, from the molecular and cellular basis of cancer through to drug discovery, translational research and clinical trials. rnThe Institute has access to outstanding laboratory facilities and exceptional core services, including next generation sequencing, microarrays, confocal microscopy, bioinformatics, histology and mass-spectrometry.

Mark Craven
Lab Services Department
About CRUK Manchester Institute

How to apply

To apply for this position please complete the online application via ‘Apply Now’ before 11:59pm on 20 January 2026.

Please note: the vacancy may close earlier if a high volume of applications is received.

For any informal enquiries about this post, please see the form below.

 

Contact us for further information

Why choose Cancer Research UK Manchester Institute?

The Cancer Research UK Manchester Institute, an Institute of The University of Manchester, is a world-leading centre for excellence in cancer research. The Institute is core funded by Cancer Research UK (www.cancerresearchuk.org),
the largest independent cancer research organisation in the world.

We are partnered with The Christie NHS Foundation Trust, one of the largest cancer treatment centres in Europe, which is located adjacent to the CRUK MI Manchester Institute in South Manchester. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.

Careers that have a lasting impact on cancer research and patient care

We are always on the lookout for talented and motivated people to join us.  Whether your background is in biological or chemical sciences, mathematics or finance, computer science or logistics, use the links below to see roles across the Institute in our core facilities, operations teams, research groups, and studentships within our exceptional graduate programme.

Gloved hands filling a stripette white lab coat

Latest from CRUK MI

Cancer Research In the Paterson Building

Find out more about the facilities across the Institute

Leukaemia Immunology & Transplantation

The Leukaemia Immunology and Transplantation laboratory aim to develop a comprehensive strategy to prevent post-transplant relapse in patients treated with allogeneic haematopoietic stem cell transplantation – the only curative therapy for many patients with acute myeloid leukaemia (AML) and other poor-risk haematological malignancies.

Patient derived preclinical models reveal novel biology of SCLC

Immune detection of dying tumour cells can elicit cancer immunity when the host permits it

Cancer Research In the Paterson Building
Leukaemia Immunology & Transplantation
Patient derived preclinical models reveal novel biology of SCLC